ICS Opens Logistics Distribution Center in Ohio
ICS distribution center will serve manufacturers of specialty medications, biosimilars, and cell and gene therapies.
ICS, a part of AmerisourceBergen, announced on Aug. 29, 2018 the opening of a third-party logistics pharmaceutical distribution center in Lockbourne, OH, which will serve as the flagship location. The largest facility in the company’s network, the 350,000-sq.-ft. distribution center will feature operations tools and technology and a logistics system to accommodate products of different sizes, temperatures, and storage needs. The facility is a certified Foreign Trade Zone Solution, which allows manufacturers to store products awaiting FDA approval in a duty-free environment.
The emergence of high-value products such as cell and gene therapies has increased the demand for rigorous and customized storage solutions, ICS reported in a press statement. The distribution center will enable the company to meet the needs for time-sensitive and ultra-frozen capabilities.
With the addition of the new facility in Ohio, ICS reports it has more than 925,000-sq.-ft .of managed warehouse at four locations within the United States.
Source: ICS, AmerisourceBergen
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
